Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study [Phase 3]
Phase 3 clinical trial exploring the dosing knowledge of CDK4/6 inhibitors in metastatic breast cancer; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Ultrasound-Guided SPSIP Versus ESPB for Postoperative Pain After Modified Radical Mastectomy [NA]
This clinical trial update indicates ongoing recruitment for a study comparing ultrasound-guided SPSIP versus ESPB for postoperative pain ma…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Impact of Emotional Skills of Young Women and Their Partner on Adjustment to Cancer [NA]
Completed clinical trial evaluating how the emotional skills of young women and their partners influence adjustment to cancer, with breast c…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Breast Cancer [NA]
A clinical trial is evaluating home-based respiratory muscle training to minimize side effects in patients undergoing treatment for breast c…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Study Evaluating the Efficacy of Loco-regional Anaesthesia PECS on Chronic Pain of a Mastectomy [NA]
This document reports a completed clinical trial evaluating the efficacy of PECS loco-regional anesthesia for chronic pain after mastectomy …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Tumor Margin Skin Tattooing Before Neo-adjuvant Chemotherapy in Patients With Breast Cancer [NA]
A clinical trial from All India Institute of Medical Sciences, Bhubaneswar is evaluating tumor margin skin tattooing before neoadjuvant chem…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Mechanical Stimulation on Pain Level and Functional Discomfort After Breast Cancer Surgery [NA]
This clinical trial update reports the termination of a study evaluating mechanical stimulation for pain and functional discomfort after bre…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03) [Phase 3]
Phase 3 TROPION-Breast03 trial evaluating datopotamab deruxtecan (Dato-DXd) with or without durvalumab versus investigator's choice in Stage…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving Surgery [NA]
This ClinicalTrials.gov update concerns a study evaluating intraoperative radiation therapy for breast cancer patients undergoing breast-con…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Access to Genetic Testing in Underserved Patients With Cancer [NA]
This entry reports on a clinical trial investigating access to genetic testing for cancer patients in underserved populations, with recruitm…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer Patients
A recruiting clinical trial studying circulating tumor cell expression and cfDNA/RNA in metastatic breast cancer patients, sponsored by Mena…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Eribulin Mesylate-based Therapy in Patients With Advanced HER2-negative Breast Cancer Previously Treated With ADC
This clinical trial update notes an eribulin mesylate–based therapy being studied for advanced HER2-negative breast cancer previously treate…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Preoperative Single-Fraction Radiotherapy in Early Stage Breast Cancer [Phase 2]
Phase 2 trial evaluating preoperative single-fraction radiotherapy for early-stage breast cancer; results have been posted.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Secondary BRain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/Pertuzumab or T-DM1 in Patients With aDvanced Human Epidermal Growth Factor Receptor 2+ brEast Cancer With the Addition of Tucatinib [Phase 2]
This Phase 2 trial investigates adding tucatinib to trastuzumab/pertuzumab or T-DM1 to prevent brain metastases in patients with advanced HE…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Multigene Risk Score Combined With Ki-67 Dynamic Assessment in Stratified Neoadjuvant Endocrine Therapy Treatment With or Without CDK4/6 Inhibitors in HR+/HER2- Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating a multigene risk score plus Ki-67 dynamic assessment to guide neoadjuvant endocrine therapy with or…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors [Phase 1]
A Phase 1 clinical trial evaluating a gene-modified immune cell therapy after a conditioning regimen for metastatic melanoma and other metas…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Letrozole, Anastrozole, Exemestane, or Tamoxifen Citrate in Treating Postmenopausal Women With Breast Cancer [Phase 3]
A Phase 3 trial comparing Letrozole, Anastrozole, Exemestane, and Tamoxifen citrate in postmenopausal women with breast cancer has completed…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update describes Phase 1/Phase 2 studies to evaluate the safety, tolerability, drug levels, and preliminary efficacy of …
-
CLINICAL_TRIALS other · 2026-03-17Clinical Trial Update: Adjuvant Radiotherapy in Breast With Intensity Modulated by Tomotherapy:
Clinical trial at Centre Oscar Lambret evaluating adjuvant radiotherapy for breast cancer using tomotherapy is currently active but not recr…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Early Phase Study of KESONOTIDE™in Participants With Solid Tumours [Phase 1, Phase 2]
KESONOTIDE is being studied in an early-phase (Phase 1/Phase 2) trial for solid tumours and is currently recruiting across multiple cancer i…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: IMPOWER-QoL: IMPact Of Discontinuing Premedication for WEekly Paclitaxel on bReast Cancer Patient's Quality Of Life [NA]
A clinical trial investigating whether discontinuing premedication for weekly paclitaxel affects quality of life in breast cancer patients; …
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
A UCSF-led clinical trial registry entry (PLUMB Registry) aims to improve survival in metastatic lobular breast cancer. The study is current…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
A clinical trial is evaluating benefits and harms of cannabis/cannabinoid use among cancer patients treated in community oncology clinics; r…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: ACT-MBC: A Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC)
ACT-MBC is a study of circulating tumor cells in metastatic breast cancer sponsored by Menarini Silicon Biosystems. The trial status is ACTI…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Fluzoparib in Combination With or Without Camrelizumab for Homologous Recombinant Deficiency (HRD) HER2 Negative Advanced Breast Cancer [Phase 2]
Phase 2 trial of Fluzoparib with or without Camrelizumab for HRD-positive, HER2-negative advanced breast cancer is currently suspended.